JP2025505933A5 - - Google Patents

Info

Publication number
JP2025505933A5
JP2025505933A5 JP2024540577A JP2024540577A JP2025505933A5 JP 2025505933 A5 JP2025505933 A5 JP 2025505933A5 JP 2024540577 A JP2024540577 A JP 2024540577A JP 2024540577 A JP2024540577 A JP 2024540577A JP 2025505933 A5 JP2025505933 A5 JP 2025505933A5
Authority
JP
Japan
Prior art keywords
seq
amino acid
acid sequence
sequence shown
antigen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024540577A
Other languages
English (en)
Japanese (ja)
Other versions
JP2025505933A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/CN2023/070928 external-priority patent/WO2023131276A1/zh
Publication of JP2025505933A publication Critical patent/JP2025505933A/ja
Publication of JP2025505933A5 publication Critical patent/JP2025505933A5/ja
Pending legal-status Critical Current

Links

JP2024540577A 2022-01-06 2023-01-06 Mslnを標的とする抗原結合タンパク質及びその使用 Pending JP2025505933A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
CN202210011545.7 2022-01-06
CN202210011545 2022-01-06
CN202210018557 2022-01-07
CN202210018557.2 2022-01-07
PCT/CN2023/070928 WO2023131276A1 (zh) 2022-01-06 2023-01-06 靶向msln的抗原结合蛋白及其应用

Publications (2)

Publication Number Publication Date
JP2025505933A JP2025505933A (ja) 2025-03-05
JP2025505933A5 true JP2025505933A5 (cg-RX-API-DMAC7.html) 2026-01-06

Family

ID=87073247

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024540577A Pending JP2025505933A (ja) 2022-01-06 2023-01-06 Mslnを標的とする抗原結合タンパク質及びその使用

Country Status (5)

Country Link
US (1) US20250213691A1 (cg-RX-API-DMAC7.html)
EP (1) EP4461747A4 (cg-RX-API-DMAC7.html)
JP (1) JP2025505933A (cg-RX-API-DMAC7.html)
CN (1) CN118510809A (cg-RX-API-DMAC7.html)
WO (1) WO2023131276A1 (cg-RX-API-DMAC7.html)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN119552270A (zh) * 2024-12-05 2025-03-04 上海怡豪生物科技有限公司 一种msln特异性嵌合抗原受体、car-t细胞及其应用

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9416190B2 (en) * 2012-09-27 2016-08-16 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Mesothelin antibodies and methods for eliciting potent antitumor activity
CN103819559B (zh) * 2013-12-10 2016-02-24 中国科学院武汉病毒研究所 一种抗间皮素纳米抗体及其编码基因和该纳米抗体的用途
US20170267755A1 (en) * 2016-03-16 2017-09-21 Sri International Isolated anti-mesothelin antibodies, conjugates and uses thereof
US20180002439A1 (en) * 2016-06-30 2018-01-04 Institut National De La Sante Et De La Recherche Medicale (Inserm) Anti-mesothelin antibodies and uses thereof
CN107840891A (zh) * 2016-09-19 2018-03-27 上海吉倍生物技术有限公司 高亲和力的抗msln抗体及其应用
SG10202107880XA (en) * 2017-05-12 2021-09-29 Harpoon Therapeutics Inc Mesothelin binding proteins
WO2019043026A1 (en) * 2017-08-30 2019-03-07 INSERM (Institut National de la Santé et de la Recherche Médicale) ANTI-MESOTHELIC RADIOMARQUATED SINGLE DOMAIN ANTIBODIES SUITABLE FOR IMAGING AND TREATING CANCERS
KR101966362B1 (ko) * 2017-10-20 2019-04-05 주식회사 녹십자 항-msln 항체 및 이를 포함하는 암 치료용 약학적 조성물
CN108129566B (zh) * 2017-12-31 2021-05-11 中国科学院武汉病毒研究所 靶向间皮素的c-型单域抗体及其制备方法与应用
EP3778876A4 (en) * 2018-03-26 2022-01-12 Origincell Therapeutics Co., Ltd. METHOD OF PROMOTING IMMUNE CELL PROLIFERATION
CA3102036A1 (en) * 2018-06-18 2019-12-26 Anwita Biosciences, Inc. Cytokine fusion proteins and uses thereof
KR102879284B1 (ko) * 2018-08-29 2025-10-31 난징 레전드 바이오테크 씨오., 엘티디. 항-메소텔린 키메라 항원 수용체(car) 작제물 및 이의 용도
CN109111528B (zh) * 2018-09-20 2021-06-22 杭州普略生物科技有限公司 以msln为靶点的嵌合抗原受体
AU2020206308B2 (en) * 2019-01-08 2026-02-05 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Cross-species single domain antibodies targeting mesothelin for treating solid tumors
CN110698562B (zh) * 2019-10-31 2022-10-25 浙江蓝盾药业有限公司 抗人msln单克隆抗体
CN111349165B (zh) * 2020-05-25 2020-09-01 南京蓝盾生物科技有限公司 抗人msln单克隆抗体及其应用
CN111560072B (zh) * 2020-07-16 2020-12-11 上海恒润达生生物科技有限公司 抗人msln抗体以及靶向msln的免疫效应细胞
CN112210008A (zh) * 2020-07-16 2021-01-12 上海恒润达生生物科技有限公司 一种新型抗人msln抗体及其用途
CN112225811A (zh) * 2020-07-16 2021-01-15 上海恒润达生生物科技有限公司 新型抗人msln抗体及其用途
CN111848819A (zh) * 2020-07-31 2020-10-30 广东昭泰体内生物医药科技有限公司 一种靶向msln的嵌合抗原受体及其应用
US20250177527A1 (en) * 2022-01-07 2025-06-05 Oricell Therapeutics Co., Ltd. Chimeric antigen receptor targeting cldn18.2 and msln and use thereof

Similar Documents

Publication Publication Date Title
JP2025028239A5 (cg-RX-API-DMAC7.html)
JP2024527557A5 (cg-RX-API-DMAC7.html)
JP2021094037A5 (cg-RX-API-DMAC7.html)
JP2021087455A5 (cg-RX-API-DMAC7.html)
JP2024534847A5 (cg-RX-API-DMAC7.html)
CN108610420B (zh) 抗cd19的人源化抗体以及靶向cd19的免疫效应细胞
IL277398B1 (en) Pd-l1 binding affimers, and uses related thereto
IL317912A (en) A combined chimeric antigen receptor targeting CD19 and CD20 and its applications
JP2020517295A5 (cg-RX-API-DMAC7.html)
JP2022523781A5 (cg-RX-API-DMAC7.html)
CA3176552A1 (en) Immune activating fc domain binding molecules
JP2024502632A5 (cg-RX-API-DMAC7.html)
EP4126946A1 (en) Bispecific antibodies comprising a modified c-terminal crossfab fragment
JP2017524367A5 (cg-RX-API-DMAC7.html)
EP3337507A1 (en) Bispecific monovalent diabodies that are capable of binding b7-h3 and cd3, and uses thereof
JP2019527557A5 (cg-RX-API-DMAC7.html)
RU2018109426A (ru) Химерные антигенные рецепторы со встроенными контролируемыми функциями
CA3180321A1 (en) Multifunctional molecules that bind to t cell related cancer cells and uses thereof
JP2018527014A5 (cg-RX-API-DMAC7.html)
CN107172880A (zh) 含有修饰IgG2结构域的引起激动或拮抗特性的修饰抗体及其用途
JP2021532742A5 (cg-RX-API-DMAC7.html)
JP2021526844A5 (cg-RX-API-DMAC7.html)
JP2023518400A (ja) 微小ガイダンス及びナビゲーションコントロール(miniGNC)抗体様タンパク質、その製造方法及び使用方法
JP2022551757A5 (cg-RX-API-DMAC7.html)
JP2024537772A5 (cg-RX-API-DMAC7.html)